Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122849393 | 12284939 | 3 | F | 20160408 | 20160627 | 20160420 | 20160701 | EXP | US-009507513-1604USA010269 | MERCK | 0.00 | F | Y | 60.32000 | KG | 20160701 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122849393 | 12284939 | 1 | PS | NUVARING | ETHINYL ESTRADIOLETONOGESTREL | 1 | Vaginal | ONE MONTHLY | Y | 21187 | VAGINAL RING | /month | |||||||
| 122849393 | 12284939 | 2 | C | EPIDUO | ADAPALENEBENZOYL PEROXIDE | 1 | Topical | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122849393 | 12284939 | 1 | Contraception |
| 122849393 | 12284939 | 2 | Acne |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122849393 | 12284939 | HO |
| 122849393 | 12284939 | LT |
| 122849393 | 12284939 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122849393 | 12284939 | Pulmonary embolism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122849393 | 12284939 | 1 | 201512 | 20160409 | 0 |